Ambrose Allison
Transaction: 06/16/2026
SELL
Change
-477
Price
$6.10
Filing
06/17/2026
Type
SELL
Upstream Bio, Inc.
UPB • Biotechnology
$6.01
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 62%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$327.95M
Growth
16.7%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 16.7%Manageable debt level · 0Healthy liquidity · 26.15Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:12 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$6.01
Change0.00%
Shares Out54.57M
Market Cap$327.95M
Enterprise Value$67.60M
52W Range5.85 - 33.68
Beta1.27
P/E-2.10
P/S103.85
P/B1.21
P/FCF-2.41
EV/Sales21.41
Price$6.01
Change0.00%
Shares Out54.57M
Market Cap$327.95M
Enterprise Value$67.60M
52W Range5.85 - 33.68
Beta1.27
P/E-2.10
P/S103.85
P/B1.21
P/FCF-2.41
EV/Sales21.41
EV/EBITDA-0.40
EV/FCF-0.50
Earnings Yield-47.72%
FCF Yield-41.57%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-56.19%
Profit Margin-50.26%
Debt/Eq0.00
Current Ratio26.15
Quick Ratio26.15
Revenue 5Y16.67%
Target$20.00
Target Upside232.78%
Target Median$20.00
Target Range15.00 - 25.00
Volume620.08K
Avg Volume593.60K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
44/100
Why this score▼
Positive revenue growth · 16.7%Manageable debt level · 0Healthy liquidity · 26.15Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
80/100
Bullish
Bullish
3
Hold
2
Bearish
0
Price Target
2026-08-13
Low
$15.00
Mean
$20.00
Median
$20.00
High
$25.00
Insider Transactions
Recent executive and insider activity
Deykin Aaron
Transaction: 06/16/2026
SELL
Change
-895
Price
$6.10
Filing
06/17/2026
Type
SELL
Houghton Adam
Transaction: 06/16/2026
SELL
Change
-700
Price
$6.10
Filing
06/17/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Ambrose Allison | SELL | -477 | $6.10 | 06/16/2026 | 06/17/2026 |
| Deykin Aaron | SELL | -895 | $6.10 | 06/16/2026 | 06/17/2026 |
| Houghton Adam | SELL | -700 | $6.10 | 06/16/2026 | 06/17/2026 |
| Sutherland Everett Rand | SELL | -2,095 | $6.10 | 06/16/2026 | 06/17/2026 |
| GRAY MICHAEL | SELL | -853 | $6.10 | 06/16/2026 | 06/17/2026 |
| Chimovits Erez | BUY | +17,096 | $6.69 | 06/09/2026 | 06/11/2026 |
| Ratcliffe Liam | BUY | +17,096 | $6.69 | 06/09/2026 | 06/11/2026 |
| Beckman Daniella | BUY | +17,096 | $6.69 | 06/09/2026 | 06/11/2026 |
| Fleming Harold Edward | BUY | +17,096 | $6.69 | 06/09/2026 | 06/11/2026 |
| Renaud Ronald C JR | BUY | +17,096 | $6.69 | 06/09/2026 | 06/11/2026 |
| Ruddy Marcella K. | BUY | +17,096 | $6.69 | 06/09/2026 | 06/11/2026 |
| Houghton Adam | SELL | -699 | $9.29 | 03/16/2026 | 03/17/2026 |
| Ambrose Allison | SELL | -475 | $9.29 | 03/16/2026 | 03/17/2026 |
| Sutherland Everett Rand | SELL | -2,093 | $9.29 | 03/16/2026 | 03/17/2026 |
| Deykin Aaron | SELL | -894 | $9.29 | 03/16/2026 | 03/17/2026 |
| GRAY MICHAEL | SELL | -852 | $9.29 | 03/16/2026 | 03/17/2026 |
| Sutherland Everett Rand | BUY | +75,000 | Not reported | 01/02/2026 | 01/06/2026 |
| Sutherland Everett Rand | BUY | +225,000 | $27.07 | 01/02/2026 | 01/06/2026 |
| Houghton Adam | BUY | +25,000 | Not reported | 01/02/2026 | 01/06/2026 |
| Houghton Adam | BUY | +75,000 | $27.07 | 01/02/2026 | 01/06/2026 |